Weight loss and muscle wasting in cancer are more than just side effects of the disease. They can shorten survival, reduce energy, and make it harder for patients to receive or recover from treatments. Current options to slow or reverse this decline are limited. Research over the past decade has made it clear that GDF15 is one of the main triggers of appetite loss and wasting in cancer.
Read MoreAstera Cancer Care is proud to announce that we have enrolled our first patient in a groundbreaking first-in-human (FIH) clinical trial, becoming the first community site in the United States to do so.
Read MoreAstera Cancer Care, an independent, physician-owned multi-specialty oncology practice, has yet again achieved another significant milestone by enrolling the world’s first patient in phase 3 of the IDeate-Lung02 clinical trial.
Read MoreAstera Cancer Care has collaborated with Allogene Therapeutics to revolutionize the landscape of CAR T cell therapy, particularly for patients with Large B-Cell Lymphoma (LBCL).
Read MoreFanni, 37, was 28 weeks pregnant when she was diagnosed with cancer. “I felt like my world ended at that moment,” Fanni recounts.
Read More